[go: up one dir, main page]

DK2726091T3 - Præparater med terapeutisk middel til fremføring i et lumen i tarmkanalen ved hjælp af en synkbar anordning til lægemiddelfremføring - Google Patents

Præparater med terapeutisk middel til fremføring i et lumen i tarmkanalen ved hjælp af en synkbar anordning til lægemiddelfremføring Download PDF

Info

Publication number
DK2726091T3
DK2726091T3 DK12803759.5T DK12803759T DK2726091T3 DK 2726091 T3 DK2726091 T3 DK 2726091T3 DK 12803759 T DK12803759 T DK 12803759T DK 2726091 T3 DK2726091 T3 DK 2726091T3
Authority
DK
Denmark
Prior art keywords
supply
syncable
lumen
preparations
gas channel
Prior art date
Application number
DK12803759.5T
Other languages
English (en)
Inventor
Mir Imran
Original Assignee
Rani Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rani Therapeutics Llc filed Critical Rani Therapeutics Llc
Application granted granted Critical
Publication of DK2726091T3 publication Critical patent/DK2726091T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/041—Capsule endoscopes for imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/07—Endoradiosondes
    • A61B5/073—Intestinal transmitters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Cell Biology (AREA)
  • Medicinal Preparation (AREA)
DK12803759.5T 2011-06-29 2012-06-29 Præparater med terapeutisk middel til fremføring i et lumen i tarmkanalen ved hjælp af en synkbar anordning til lægemiddelfremføring DK2726091T3 (da)

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US201161571641P 2011-06-29 2011-06-29
US201161571679P 2011-06-29 2011-06-29
US201161571632P 2011-06-29 2011-06-29
US201161571633P 2011-06-29 2011-06-29
US201161571634P 2011-06-29 2011-06-29
US201161571687P 2011-06-29 2011-06-29
US201161571686P 2011-06-29 2011-06-29
US201161571643P 2011-06-29 2011-06-29
US201161571619P 2011-06-30 2011-06-30
US201161571642P 2011-06-30 2011-06-30
US201161571650P 2011-06-30 2011-06-30
US201161571648P 2011-06-30 2011-06-30
US201161571652P 2011-06-30 2011-06-30
US201161571631P 2011-06-30 2011-06-30
US201161571649P 2011-06-30 2011-06-30
PCT/US2012/045138 WO2013003824A1 (en) 2011-06-29 2012-06-29 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Publications (1)

Publication Number Publication Date
DK2726091T3 true DK2726091T3 (da) 2020-03-09

Family

ID=47424583

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12803759.5T DK2726091T3 (da) 2011-06-29 2012-06-29 Præparater med terapeutisk middel til fremføring i et lumen i tarmkanalen ved hjælp af en synkbar anordning til lægemiddelfremføring

Country Status (10)

Country Link
EP (2) EP2726091B1 (da)
JP (5) JP6029664B2 (da)
CN (2) CN104023740B (da)
AU (1) AU2012275112B2 (da)
CA (2) CA3070695C (da)
DK (1) DK2726091T3 (da)
ES (1) ES2773115T3 (da)
PL (1) PL2726091T3 (da)
PT (1) PT2726091T (da)
WO (1) WO2013003824A1 (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011017335A1 (en) 2009-08-03 2011-02-10 Incube Labs, Llc Swallowable capsule and method for stimulating incretin production within the intestinal tract
US8721620B2 (en) 2009-12-24 2014-05-13 Rani Therapeutics, Llc Swallowable drug delivery device and methods of drug delivery
CN103249401B (zh) 2010-09-15 2016-01-20 兰德尔·J·米斯尼 使用细菌毒素衍生的转运序列递送生物活性剂的系统和方法
US11246915B2 (en) 2010-09-15 2022-02-15 Applied Molecular Transport Inc. Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
US10639272B2 (en) 2010-12-23 2020-05-05 Rani Therapeutics, Llc Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
US8734429B2 (en) 2010-12-23 2014-05-27 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9415004B2 (en) 2010-12-23 2016-08-16 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9284367B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809269B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9259386B2 (en) 2010-12-23 2016-02-16 Rani Therapeutics, Llc Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8980822B2 (en) 2010-12-23 2015-03-17 Rani Therapeutics, Llc Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402806B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9629799B2 (en) 2010-12-23 2017-04-25 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9149617B2 (en) 2010-12-23 2015-10-06 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9283179B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8969293B2 (en) 2010-12-23 2015-03-03 Rani Therapeutics, Llc Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8846040B2 (en) 2010-12-23 2014-09-30 Rani Therapeutics, Llc Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402807B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8809271B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8764733B2 (en) 2010-12-23 2014-07-01 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9861683B2 (en) 2010-12-23 2018-01-09 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
WO2013003824A1 (en) * 2011-06-29 2013-01-03 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
EP2968071B1 (en) * 2013-03-15 2021-08-04 Rani Therapeutics, LLC Device for oral delivery of therapeutic compounds
PT3139965T (pt) 2014-05-07 2021-12-27 Applied Molecular Transp Llc Moléculas de fusão derivadas de toxinas cholix para administração oral de carga biologicamente ativa
US11548940B2 (en) 2014-05-15 2023-01-10 Rani Therapeutics, Llc Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US10689460B2 (en) 2014-05-15 2020-06-23 Incube Labs, Llc PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
AU2015258859B2 (en) 2014-05-15 2020-07-23 Rani Therapeutics, Llc Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
CN107106147B (zh) * 2014-09-17 2020-11-10 马斯公司 装置
CN107106148B (zh) 2014-09-17 2020-09-11 马斯公司 采样装置及获得动物的胃肠道中的样本的方法
CN107847446A (zh) * 2015-05-01 2018-03-27 因库博实验室有限责任公司 药物组合物和用于制备包含多肽和/或蛋白质的固体块的方法
EP3294273A4 (en) * 2015-05-08 2018-12-05 Incube Labs, LLC Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
CA2993215C (en) * 2015-07-02 2023-10-31 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
AU2016320867B2 (en) * 2015-09-08 2023-03-30 Rani Therapeutics, Llc PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
JP7097816B2 (ja) * 2016-03-09 2022-07-08 インキューブ ラブズ， エルエルシー 中実組織中に生存細胞を送達するための方法および物品
CA3036364A1 (en) 2016-09-09 2018-03-15 Mitchell Lawrence Jones Electromechanical ingestible device for delivery of a dispensable substance
CA3054632A1 (en) * 2017-03-30 2018-10-04 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device
CN108095806B (zh) * 2017-12-16 2023-04-28 重庆金山科技（集团）有限公司 带自锁功能的吸附穿刺固定装置
CN111511434B (zh) * 2017-12-18 2023-03-17 柏欧格瑞有限责任公司 活性药物物质的口服递送
SI3762009T1 (sl) 2018-03-08 2023-03-31 Applied Molecular Transport Inc. Iz toksinov izpeljani dostavni konstrukti za peroralno dostavo
EP3773407B1 (en) * 2018-03-30 2025-08-27 Vibrant Ltd. Gastrointestinal treatment system including a vibrating capsule, and method of use thereof
US20200038000A1 (en) * 2018-08-06 2020-02-06 Nimble Science Ltd. Ingestible apparatus and method for collecting samples in the gastrointestinal tract and/or delivering health-related fluid thereto
US12128133B2 (en) * 2018-09-25 2024-10-29 Rani Therapeutics, Llc Ingestible device with expandable enclosure
DK3650037T3 (da) 2018-11-07 2022-05-02 Applied Molecular Transport Inc Indgivelseskonstrukter til transcytose og tilhørende fremgangsmåder
EP3826682A4 (en) 2018-11-07 2021-11-17 Applied Molecular Transport Inc. CHOLIX-DERIVED MEDIA FOR ORAL HETEROLOGICAL LOADING ADMINISTRATION
CN116726361A (zh) 2018-11-19 2023-09-12 比奥拉治疗股份有限公司 用生物治疗剂治疗疾病的方法和装置
CN113543756B (zh) * 2018-12-31 2023-09-05 拉尼医疗有限公司 使用可吞服药物递送装置递送到肠道内腔的治疗剂制剂
JP2022523121A (ja) * 2019-02-01 2022-04-21 マサチューセッツ インスティテュート オブ テクノロジー 液体注入のためのシステムおよび方法
MX2022001975A (es) 2019-08-16 2022-03-11 Applied Molecular Transport Inc Composiciones, formulaciones y produccion y purificacion de interleucinas.
US11707610B2 (en) 2019-12-13 2023-07-25 Biora Therapeutics, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
US20230076683A1 (en) * 2021-09-03 2023-03-09 Alma Therapeutics Ltd Controlled Release Formulations and Methods of Targeted Drug Delivery within the Small Intestine Wall
US20250295592A1 (en) * 2024-03-20 2025-09-25 Jes Tougaard Gram Method for Controlled Release Oral Drug Delivery

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60129057A (ja) * 1983-12-14 1985-07-10 住友化学工業株式会社 針状固形製剤投与針
DK42093D0 (da) * 1993-04-07 1993-04-07 Bukh Meditec Administrationsmetode
GB2404865B (en) * 2001-09-11 2005-09-28 Caretek Medical Ltd Novel drug delivery technology
EP1534376B1 (en) * 2002-06-25 2016-08-31 Theraject, Inc. Rapidly dissolving micro-perforator for drug delivery and other applications
US8062573B2 (en) * 2002-09-16 2011-11-22 Theraject, Inc. Solid micro-perforators and methods of use
JP2006512130A (ja) * 2002-12-26 2006-04-13 ギブン・イメージング・リミテツド 不動化可能な生体内センシング装置
CA2514392A1 (en) * 2003-01-29 2004-08-12 E-Pill Pharma Ltd. Active drug delivery in the gastrointestinal tract
FR2854072B1 (fr) * 2003-04-23 2006-08-04 Centre Nat Rech Scient Vecteur pour administration par voie orale
JP2008532568A (ja) * 2005-01-18 2008-08-21 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 電子制御されるカプセル
JP4402648B2 (ja) * 2005-12-16 2010-01-20 オリンパス株式会社 被検体内導入装置
GB0603252D0 (en) * 2006-02-17 2006-03-29 Axcess Ltd Dissolution aids for oral peptide delivery
NZ589390A (en) * 2008-05-05 2011-11-25 Oramed Ltd Methods and compositions for oral administration of exenatide
WO2010093834A2 (en) * 2009-02-12 2010-08-19 Incube Labs, Llc Skin penetrating device and method for subcutaneous solid drug delivery
HUP0900482A2 (en) * 2009-08-03 2011-03-28 Cera Med Kft Pharmaceutical formulation for oral administration
EP3756657B1 (en) * 2009-12-24 2025-03-05 Rani Therapeutics, LLC Swallowable drug delivery device
US8721620B2 (en) * 2009-12-24 2014-05-13 Rani Therapeutics, Llc Swallowable drug delivery device and methods of drug delivery
WO2013003824A1 (en) * 2011-06-29 2013-01-03 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Also Published As

Publication number Publication date
EP3653224A1 (en) 2020-05-20
JP6745866B2 (ja) 2020-08-26
JP6029664B2 (ja) 2016-11-24
JP2020192342A (ja) 2020-12-03
JP2019043967A (ja) 2019-03-22
EP2726091B1 (en) 2020-01-22
JP7102470B2 (ja) 2022-07-19
JP2022126686A (ja) 2022-08-30
JP2016193946A (ja) 2016-11-17
AU2012275112B2 (en) 2017-07-06
CA2840617A1 (en) 2013-01-03
AU2012275112A1 (en) 2014-01-23
CA2840617C (en) 2020-03-24
CA3070695A1 (en) 2013-01-03
PT2726091T (pt) 2020-04-22
EP2726091A1 (en) 2014-05-07
CN104023740A (zh) 2014-09-03
EP2726091A4 (en) 2015-04-15
JP2014520812A (ja) 2014-08-25
JP6663326B2 (ja) 2020-03-11
WO2013003824A1 (en) 2013-01-03
CA3070695C (en) 2024-01-23
CN109008910B (zh) 2024-07-26
PL2726091T3 (pl) 2020-08-10
ES2773115T3 (es) 2020-07-09
JP7305008B2 (ja) 2023-07-07
CN109008910A (zh) 2018-12-18
CN104023740B (zh) 2018-10-02

Similar Documents

Publication Publication Date Title
DK2726091T3 (da) Præparater med terapeutisk middel til fremføring i et lumen i tarmkanalen ved hjælp af en synkbar anordning til lægemiddelfremføring
DK2890433T3 (da) Drivmekanisme med kontrolleret administation til lægemiddeladministrationspumper
DK2704776T3 (da) Enhed til en lægemiddelfremføringsanordning og lægemiddelfremføringsanordning
PL2753382T3 (pl) Urządzenie do automatycznego wstrzykiwania dawek leku
DK2726141T3 (da) Enhed til oral levering af terapeutiske forbindelser
DK2736478T3 (da) Ventilarrangement til anvendelse med en væskebeholder og en medikamentampul
HUE043538T2 (hu) Dózisvezetõ eszköz injekciós fecskendõhöz
DK2641614T3 (da) Farmaceutisk præparat integreret med mikronåle til hudbehandling
DK2782630T3 (da) Medikamentleveringssystem med en forsinkelsesmekanisme
DK2849567T3 (da) Bærestoffer til forbedret lægemiddeladministration
DK2665503T3 (da) Medikamenttilførselsanordning
DK2686047T3 (da) Drivmekanisme til medicinafgivelsesanordning samt medicinafgivelsesanordning
DK3400981T3 (da) Fremgangsmåde og overvågningsanordning til overvågning af driften af en lægemiddelindgivelsesanordning
DK2768559T3 (da) Lægemiddelindgivelsesanordning
DK2714135T3 (da) Medikamentadministrationsanordning og fremgangsmåde til styring af anordningen
IL232251B (en) Pharmaceutical combination for use in the treatment of type 2 diabetes patients
DK2563450T3 (da) Apparat til administration af rheumatoid-arthritis-medikament
DK2452281T3 (da) Fremgangsmåde til at forudsige virkningen af lægemidler i en patient
IL230838A0 (en) Pharmaceutical compositions
IL228441A0 (en) Controlled-release pharmaceutical dosage forms
DK2704778T3 (da) Drivindretning til en lægemiddeladministrationsanordning og tilsvarende lægemiddeladministrationsanordning
DK2790758T3 (da) Kassette til en lægemiddeldosis og tilførselsindretning
IL228753A0 (en) Safety syringe for a needle-free injection device
DK2740504T3 (da) Lægemiddelfremføringsanordning
PL2773648T3 (pl) Związki farmaceutyczne do zastosowania w terapii zakażenia clostridium difficile